Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using FDG PET in luminal HER2-negative breast cancer.
Olivier Humbert
No relevant relationships to disclose
Alina Berriolo-Riedinger
No relevant relationships to disclose
Alexandre Cochet
No relevant relationships to disclose
Mélanie Gauthier
No relevant relationships to disclose
Celine Charon-Barra
No relevant relationships to disclose
Isabelle Desmoulins
No relevant relationships to disclose
Séverine Guiu
No relevant relationships to disclose
Michel Toubeau
No relevant relationships to disclose
Inna Dygai-Cochet
No relevant relationships to disclose
Charles Coutant
No relevant relationships to disclose
Pierre Fumoleau
Consultant or Advisory Role - Janssen (U); Roche (U); Sanofi (U)
Francois Brunotte
No relevant relationships to disclose